Quality of life of patients with type 2 diabetes in relation to method of treatment

• Autorzy: Dudzinska M. , Tarach J.S. , Zwolak A. , Malicka J. , Kowalczyk M. , Daniluk J.
• Języki publikacji: EN

Abstrakty

EN

Słowa kluczowe

EN

life quality; patient; diabetes type 2; treatment method; insulin therapy; human disease

• Wydawca: -
• Czasopismo: Health Problems of Civilization
• Rocznik: 2015
• Tom: 09
• Numer: 4
• Opis fizyczny: p.26-31,ref.

Twórcy

autor

Dudzinska M.

• Chair of Internal Medicine, Department of Internal Medicine in Nursing, Medical University of Lublin, Jaczewskiego 8, 20-954 Lublin, Poland
• Department of Endocrinology, Medical University of Lublin, Lublin, Poland

autor

Tarach J.S.

• Department of Endocrinology, Medical University of Lublin, Lublin, Poland

autor

Zwolak A.

• Chair of Internal Medicine, Department of Internal Medicine in Nursing, Medical University of Lublin, Jaczewskiego 8, 20-954 Lublin, Poland
• Department of Endocrinology, Medical University of Lublin, Lublin, Poland
• Department of Health, John Paul II State School of Higher Education in Biała Podlaska, Biala Podlaska, Poland

autor

Malicka J.

• Department of Endocrinology, Medical University of Lublin, Lublin, Poland

autor

Kowalczyk M.

• Department of Endocrinology, Medical University of Lublin, Lublin, Poland

autor

Daniluk J.

• Department of Health, John Paul II State School of Higher Education in Biała Podlaska, Biala Podlaska, Poland

Bibliografia

• 1. Arbuckle R.A., Humphrey L., Vardeva K., Arondekar B., Danten-Viala M., Scott J.A., Snoek FJ. (2009), Psychometric Evaluation of the Diabetes Symptom Checklist-Revised (DSC-R)—A Measure of Symptom Distress. Value in Health, 12: 1168-1175.
• 2. Burroughs T.E., Desikan R., Waterman B.M., Gilin D., McGill J. (2004), Development and Validation of the Diabetes Quality of Life Brief Clinical Inventory. Diabetes Spectrum, 17: 41-49.
• 3. Burroughs T.E. (2006), Development and Validation of Diabetes Quality of Life- Brief Clinical Inventory. Administrator’s Manual, v3.2 . Saint Louis University Center for Outcomes Research, Saint Louis.
• 4. Davis T.M., Clifford R.M., Davis W.A. (2001), Effect of insulin therapy on quality of life in type 2 diabetes mellitus: The Fremantle Diabetes Study. Diabetes Research and Clinical Practice, 52: 63-71.
• 5. Diabetes Care and Research in Europe: the St Vincent Declaration (1989), 1st Meeting of St Vincent Declaration Diabetes Action Programme, St Vincent, Italy.
• 6. Dudzińska M., Tarach J.S., Matuszek B., Kowalczyk M., Wdowiak-Barton B., Kiszczak-Bochyńska E., Nowakowski A. (2011), Evaluation of metabolic control in patients with type 2 diabetes depending on the type of hypoglycemic treatment. Experimental and Clinical Diabetology, 11: 1-7.
• 7. Dudzińska M., Tarach J.S., Malicka J., Kurowska M., Kowalczyk M., Nowakowski A. (2011), Why, when and how insulin therapy is being started for patients with type 2 diabetes treated with oral medications: an observation Quality of life of patients with type 2 diabetes...study. Experimental and Clinical Diabetology, 11: 45-50.
• 8. Dudzińska M., Tarach J.S., Burroughs T.E., Zwolak A., Matuszek B., Smoleń A., Nowakowski A. (2014), Validation of the Polish version of Diabetes Quality of Life - Brief Clinical Inventory (DQL-BCI) among patients with type 2 diabetes. Archives of Medical Science (in press).
• 9. Golicki D., Jakubczyk M., Niewada M., Wrona W., Busschbach J.J. (2010), Valuation of EQ-5D health states in Poland: first TTO-based social value set in Central and Eastern Europe. Value Health, 13: 289-297.
• 10. Grootenhuis P.A., Snoek F.J., Heine R.J., Bouter L.M. (1994), Development of type 2 Diabetes Symptom Checklist: a Measure of Symptom Severity. Diabetic Medicine, 11: 253-261.
• 11. Jacobson A.M., De Groot M., Samson J.A. (1994), The evaluation of two measures of quality of life in patients with type I and II diabetes. Diabetes Care, 17: 267-274.
• 12. Kleefstra N., Ubink-Veltmaat L.J., Houweling S.T., Groenier K.H., Meyboom-de Jong B., Bilo H.J. (2005), Crosssectional relationship between glycaemic control, hyperglycaemic symptoms and quality of life in type 2 diabetes (ZODIAC-2). Neth J Med. 63: 215-221.
• 13. Koopmanschap M. (2002), Coping with type II diabetes: the patient’s perspective. Diabetologia, 45:S18-22.
• 14. Lewko J., Polityńska B., Kochanowicz J., Zarzycki W., Okruszko A., Sierakowska M., Jankowiak B., Górska M., Krajewska-Kułak E., Kowalczuk K. (2007), Quality of life and its relationship to the degree of illness acceptance in patients with diabetes and peripheral diabetic neuropathy. Advances in Medical Sciences, 52(Suppl.1): 144- 146.
• 15. Mapi Research Trust: www.mapi-trust.org (accessed: 05.08.2014).
• 16. Piberinik-Okanović M., Szabo S., Metelko Z. (1998), Quality of life following a change in therapy for diabetes mellitus. Pharmacoeconomics, 14:201-204.
• 17. Ptasiński A., Pączek L. (2008), Influence of diabetes on quality of life- assessment with use of ADDQL questionnaire in general practice. Medycyna Metaboliczna, 12: 45-48.
• 18. Pufal J., Gierach M., Pufal M., Bronisz A., Kiełbasa L., Junik R. (2004), The influence of socio-demographic and clinical factors on quality of life of patients with type 2 diabetes. Experimental and Clinical Diabetology, 4:137- 143.
• 19. Solli O., Stavem K., Kristiansen I.S. (2010), Health-related quality of life in diabetes: The associations of complications with EQ-5D scores. Health Qual Life Outcomes, 4; 8-18.
• 20. Sparring V., Nyström L., Wahlström R., Jonsson P.M., Ostman J., Burström K. (2013), Diabetes duration and health-related quality of life in individuals with onset of diabetes in the age group 15-34 years - a Swedish population-based study using EQ-5D. BMC Public Health, 13:377.
• 21. Szende A., Williams A. (2004), Measuring Self-Reported Population Health: An International Perspective based on EQ-5D. EuroQol Group. SpringMEDPublishing.
• 22. Testa M.A., Simonson D.C. (1998), Health economic benefits and quality of life during improved glycemic control in patients with type 2 diabetes mellitus: a randomized, controlled double blind trial. JAMA, 280: 1490-1496.
• 23. U.K. Prospective Diabetes Study Group: Quality of life type 2 diabetic patients is affected by complications but not by intensive polices to improve blood glucose or blood pressure control (UKPDS37). (1999) Diabetes Care, 22: 1125-1136.

Identyfikatory

DOI

10.5114/hpc.2015.57698